Clinical experience in the use of cefuroxime in gonorrhoea.
AUTOR(ES)
Fowler, W
RESUMO
Cefuroxime, a new antibiotic derived from cephalosporin-C which is very stable in the presence of beta-lactamases produced by Gram-negative organisms, was used to treat 856 male patients and 340 female patients with uncomplicated gonorrhoea. In men the drug was used in three different doses, 1.5 g, 1 g, and 750 mg plus 1 g probenecid; in women 1 g and 750 mg cefuroxime plus 1 g probenecid was used. Cure rates ranged from 94.8% to 99.3%. The antibiotic was well tolerated and was free from side effects. Cefuroxime would be a valuable and efficient substitute for penicillin in the treatment of gonorrhoea due to beta-lactamase-producing strains of gonococci.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045558Documentos Relacionados
- Epidemiological measures against gonorrhoea. Experience in Greenland.
- Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhoea.
- Oral ampicillin in gonorrhoea. Clinical evaluation.
- Prolonged use of the Greenland method of treatment of gonorrhoea.
- Demethylchlortetracycline in the treatment of gonorrhoea.